Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Generation Bio Co. (GBIO)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 59,420,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Generation Bio is a genetic medicines company providing durable, redosable treatments for potentially various of patients living with rare and prevalent diseases. Co.'s non-viral genetic medicine platform incorporates its DNA construct called closed-ended DNA; its cell-targeted lipid nanoparticle delivery system; and its capsid-free manufacturing process that uses its proprietary cell-free rapid enzymatic synthesis, to produce ceDNA. Using Co.'s platform, it is developing genetic medicines to provide targeted delivery of genetic payloads that include large and multiple genes to a range of cell types across a range of diseases.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 551,455 551,455 642,217
Total Buy Value $0 $778,895 $778,895 $1,265,385
Total People Bought 0 4 4 4
Total Buy Transactions 0 7 7 12
Total Shares Sold 0 4,890 11,122 27,899
Total Sell Value $0 $7,922 $39,768 $125,583
Total People Sold 0 2 2 2
Total Sell Transactions 0 2 4 10
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 293
  Page 10 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Stanton Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2021-03-10 4 AS $34.57 $367,210 D/D (10,500) 198,154     -
   Stanton Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2021-03-10 4 OE $0.60 $6,300 D/D 10,500 208,654     -
   Kerr Douglas CHIEF MEDICAL OFFICER   •       –      –    2021-03-05 4 AS $29.68 $354,267 D/D (11,267) 326,558     -
   Kerr Douglas CHIEF MEDICAL OFFICER   •       –      –    2021-03-05 4 OE $4.59 $51,716 D/D 11,267 337,825     -
   Zimmermann Tracy CHIEF DEVELOPMENT OFFICER   •       –      –    2021-03-03 4 AS $41.38 $124,140 D/D (3,000) 0     -
   Zimmermann Tracy CHIEF DEVELOPMENT OFFICER   •       –      –    2021-03-03 4 OE $4.59 $13,770 D/D 3,000 3,000     -
   Zimmermann Tracy CHIEF DEVELOPMENT OFFICER   •       –      –    2021-03-01 4 AS $35.75 $97,099 D/D (2,500) 0     -
   Zimmermann Tracy CHIEF DEVELOPMENT OFFICER   •       –      –    2021-03-01 4 OE $4.59 $11,475 D/D 2,500 2,500     -
   Mcdonough Geoff PRESIDENT AND CEO   •       •      –    2021-03-01 4 AS $36.35 $375,801 D/D (10,000) 1,194,080     -
   Stanton Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2021-02-10 4 AS $33.59 $359,856 D/D (10,400) 198,154     -
   Stanton Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2021-02-10 4 OE $0.60 $6,240 D/D 10,400 208,554     -
   Kerr Douglas CHIEF MEDICAL OFFICER   •       –      –    2021-02-08 4 AS $33.01 $375,954 D/D (11,267) 326,558     -
   Kerr Douglas CHIEF MEDICAL OFFICER   •       –      –    2021-02-08 4 OE $4.59 $51,716 D/D 11,267 337,825     -
   Zimmermann Tracy CHIEF DEVELOPMENT OFFICER   •       –      –    2021-02-02 4 AS $33.05 $82,625 D/D (2,500) 0     -
   Zimmermann Tracy CHIEF DEVELOPMENT OFFICER   •       –      –    2021-02-02 4 OE $4.59 $11,475 D/D 2,500 2,500     -
   Angelino Mark D. CHIEF OPERATING OFFICER   •       –      –    2021-01-15 4 AS $32.29 $247,273 D/D (7,500) 345,637     -
   Angelino Mark D. CHIEF OPERATING OFFICER   •       –      –    2021-01-15 4 OE $4.59 $34,425 D/D 7,500 353,137     -
   Zimmermann Tracy CHIEF DEVELOPMENT OFFICER   •       –      –    2021-01-14 4 AS $33.09 $82,725 D/D (2,500) 0     -
   Zimmermann Tracy CHIEF DEVELOPMENT OFFICER   •       –      –    2021-01-14 4 OE $4.59 $11,475 D/D 2,500 2,500     -
   Stanton Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2021-01-14 4 AS $31.11 $183,212 D/D (5,630) 198,154     -
   Stanton Matthew CHIEF SCIENTIFIC OFFICER   •       –      –    2021-01-14 4 OE $0.60 $3,378 D/D 5,630 203,784     -
   Mcdonough Geoff PRESIDENT AND CEO   •       •      –    2021-01-13 4 GA $0.00 $0 I/I 275,000 275,000     -
   Mcdonough Geoff PRESIDENT AND CEO   •       •      –    2021-01-13 4 GD $0.00 $0 D/D 275,000 1,204,080     -
   Rowland Charles A Jr   –       •      –    2021-01-11 4 B $24.50 $499,996 D/D 20,408 101,035 0.01     -
   Kerr Douglas CHIEF MEDICAL OFFICER   •       –      –    2021-01-11 4 AS $27.17 $310,768 D/D (11,267) 326,558     -
  293 Records found
  Previous  10  11  12   
  Page 10 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us